loadpatents
name:-0.035806894302368
name:-0.018312931060791
name:-0.0056459903717041
Dodd; John H. Patent Filings

Dodd; John H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dodd; John H..The latest application filed is for "orally active melanocortin receptor-4 compounds".

Company Profile
5.21.30
  • Dodd; John H. - Spring Mills PA
  • Dodd; John H. - Spring Mils PA
  • Dodd; John H - Spring Mills PA
  • Dodd; John H. - Flemington NJ
  • Dodd; John H. - Cranbury NJ
  • Dodd; John H. - Stockton NJ
  • Dodd; John H. - Pittstown NJ
  • Dodd, John H. - Stochton NJ
  • Dodd; John H. - Lebanon NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Orally Active Melanocortin Receptor-4 Compounds
App 20220204450 - Bullington; James ;   et al.
2022-06-30
Therapies for Obesity, Diabetes and Related Indications
App 20200276275 - Spana; Carl ;   et al.
2020-09-03
Therapies for obesity, diabetes and related indications
Grant 10,660,939 - Spana , et al.
2020-05-26
Melanocortin receptor-specific peptides
Grant 10,632,171 - Shi , et al.
2020-04-28
Melanocortin Receptor-Specific Peptides
App 20190216887 - Shi; Yi-qun ;   et al.
2019-07-18
Melanocortin receptor-specific peptides
Grant 10,179,804 - Shi , et al. Ja
2019-01-15
Compounds inhibiting eukaryotic elongation factor 2 kinase activity
Grant 10,106,552 - Dodd October 23, 2
2018-10-23
Therapies for Obesity, Diabetes and Related Indications
App 20180153965 - Spana; Carl ;   et al.
2018-06-07
Replacement Therapy for Natriuretic Peptide Deficiencies
App 20170087205 - Spana; Carl ;   et al.
2017-03-30
Replacement Therapy for Natriuretic Peptide Deficiencies
App 20160354443 - Spana; Carl ;   et al.
2016-12-08
Melanocortin Receptor-Specific Peptides
App 20160318977 - Shi; Yi-qun ;   et al.
2016-11-03
Compounds Inhibiting Eukaryotic Elongation Factor 2 Kinase Activity
App 20160318948 - Dodd; John H.
2016-11-03
Melanocortin receptor-specific heptapeptides
Grant 9,458,201 - Shi , et al. October 4, 2
2016-10-04
Melanocortin Receptor-Specific Peptides
App 20150252077 - Dodd; John H. ;   et al.
2015-09-10
Melanocortin receptor-specific peptides
Grant 9,040,663 - Dodd , et al. May 26, 2
2015-05-26
Melanocortin Receptor-Specific Heptapeptides
App 20140357575 - Shi; Yi-qun ;   et al.
2014-12-04
Melanocortin receptor-specific peptides
Grant 8,846,601 - Shi , et al. September 30, 2
2014-09-30
Melanocortin Receptor-Specific Peptides
App 20130237473 - Dodd; John H. ;   et al.
2013-09-12
Melanocortin receptor-specific peptides
Grant 8,455,618 - Dodd , et al. June 4, 2
2013-06-04
Melanocortin receptor-specific peptides
Grant 8,455,617 - Dodd , et al. June 4, 2
2013-06-04
Melanocortin receptor-specific spiro-piperidine compounds
Grant 8,263,608 - Shi , et al. September 11, 2
2012-09-11
Melanocortin Receptor-Specific Peptides
App 20120178701 - Shi; Yi-qun ;   et al.
2012-07-12
Melanocortin Receptor-specific Peptides
App 20120046219 - DODD; John H. ;   et al.
2012-02-23
Melanocortin Receptor-Specific Spiro-Piperidine Compounds
App 20110178080 - Shi; Yi-Qun ;   et al.
2011-07-21
Melanocortin Receptor-specific Peptides
App 20100311648 - DODD; John H. ;   et al.
2010-12-09
Arylindenopyridines and related therapeutic and prophylactic methods
App 20060154949 - Heintzelman; Geoffrey R. ;   et al.
2006-07-13
Arylindenopyridines and related therapeutic and prophylactic methods
App 20060009481 - Heintzelman; Geoffrey R. ;   et al.
2006-01-12
Arylindenopyridines and related therapeutic and prophylactic methods
App 20050277637 - Heintzelman, Geoffrey R. ;   et al.
2005-12-15
Arylindenopyridines and related therapeutic and prophylactic methods
App 20050239782 - Heintzelman, Geoffrey R. ;   et al.
2005-10-27
Arylindenopyridines and related therapeutic and prophylactic methods
Grant 6,958,328 - Heintzelman , et al. October 25, 2
2005-10-25
Arylindenopyridines and related therapeutic and prophylactic methods
Grant 6,903,109 - Heintzelman , et al. June 7, 2
2005-06-07
Anti-inflammatory coatings for implantable medical devices and devices containing said coatings
App 20040120977 - Dodd, John H.
2004-06-24
Arylindenopyridines and related therapeutic and prophylactic methods
App 20040082578 - Heintzelman, Geoffrey R. ;   et al.
2004-04-29
Dihydropyridine soft drugs, and related compositions and methods
App 20030225120 - Dodd, John H. ;   et al.
2003-12-04
Arylindenopyridines and related therapeutic and prophylactic methods
App 20030212089 - Heintzelman, Geoffrey R. ;   et al.
2003-11-13
Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods
Grant 6,610,697 - Dodd , et al. August 26, 2
2003-08-26
Dual inhibitorsof PDE 7 and PDE 4
App 20030104974 - Pitts, William J. ;   et al.
2003-06-05
Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods
Grant 6,472,530 - Dodd , et al. October 29, 2
2002-10-29
Dihydropyridine soft drugs, and related compositions and methods
App 20020133018 - Dodd, John H. ;   et al.
2002-09-19
Dithiepino[6,5-b]pyridines, and related compositions and methods
App 20020103376 - Bullington, James L. ;   et al.
2002-08-01
Benzoether and related compositions and methods
App 20020049325 - Dodd, John H. ;   et al.
2002-04-25
Benzosulfones and related compositions and methods
App 20020049326 - Dodd, John H. ;   et al.
2002-04-25
Dithiepino[6,5-b]pyridines, and related compositions and methods
App 20020032332 - Bullington, James L. ;   et al.
2002-03-14
Dithiepino [6,5-b]pyridines, and related compositions and methods
App 20020026051 - Bullington, James L. ;   et al.
2002-02-28
Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
Grant 5,075,440 - Wustrow , et al. December 24, 1
1991-12-24
Preparation of thiocycloalkno [3,2-b] pyridines
Grant 4,879,384 - Schwender , et al. November 7, 1
1989-11-07
Substituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agents
Grant 4,745,123 - Butler , et al. May 17, 1
1988-05-17
Substituted 5,6-dialkoxyquinazoline derivatives
Grant 4,672,116 - Bandurco , et al. June 9, 1
1987-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed